TREMFYA Janssen-Cilag Pty Ltd
Product name
TREMFYA
Sponsor
Accepted date
Aug-2024
Active ingredients
guselkumab
Proposed indication
For the treatment of adult patients with moderately to severely active ulcerative colitis or Crohn’s disease
Application type
C (new indication)
Publication date
Aug-2024